Teladoc Health, Inc. (LON:0LDR)

Teladoc Health Statistics

Total Valuation

Teladoc Health has a market cap or net worth of GBP 716.27 million. The enterprise value is 910.70 million.

Market Cap	716.27M
Enterprise Value	910.70M

Important Dates

The last earnings date was Wednesday, February 25, 2026.

Earnings Date	Feb 25, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	178.40M
Shares Outstanding	n/a
Shares Change (YoY)	+3.32%
Shares Change (QoQ)	+0.51%
Owned by Insiders (%)	1.21%
Owned by Institutions (%)	74.69%
Float	176.24M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.38
PB Ratio	0.70
P/TBV Ratio	n/a
P/FCF Ratio	3.38
P/OCF Ratio	3.28
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 26.11, with an EV/FCF ratio of 4.29.

EV / Earnings	-6.12
EV / Sales	0.48
EV / EBITDA	26.11
EV / EBIT	n/a
EV / FCF	4.29

Financial Position

The company has a current ratio of 2.77, with a Debt / Equity ratio of 0.75.

Current Ratio	2.77
Quick Ratio	2.43
Debt / Equity	0.75
Debt / EBITDA	22.38
Debt / FCF	3.64
Interest Coverage	-8.29

Financial Efficiency

Return on equity (ROE) is -13.93% and return on invested capital (ROIC) is -3.71%.

Return on Equity (ROE)	-13.93%
Return on Assets (ROA)	-3.20%
Return on Invested Capital (ROIC)	-3.71%
Return on Capital Employed (ROCE)	-6.66%
Weighted Average Cost of Capital (WACC)	8.62%
Revenue Per Employee	366,857
Profits Per Employee	-29,047
Employee Count	5,600
Asset Turnover	0.79
Inventory Turnover	20.21

Taxes

Income Tax	-26.16M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -37.24% in the last 52 weeks. The beta is 2.19, so Teladoc Health's price volatility has been higher than the market average.

Beta (5Y)	2.19
52-Week Price Change	-37.24%
50-Day Moving Average	5.50
200-Day Moving Average	7.20
Relative Strength Index (RSI)	50.74
Average Volume (20 Days)	42,122

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	4.90

Income Statement

In the last 12 months, Teladoc Health had revenue of GBP 1.88 billion and -148.84 million in losses. Loss per share was -0.84.

Revenue	1.88B
Gross Profit	1.31B
Operating Income	-121.40M
Pretax Income	-175.00M
Net Income	-148.84M
EBITDA	24.57M
EBIT	-121.40M
Loss Per Share	-0.84

Balance Sheet

The company has 580.35 million in cash and 772.84 million in debt, with a net cash position of -192.50 million.

Cash & Cash Equivalents	580.35M
Total Debt	772.84M
Net Cash	-192.50M
Net Cash Per Share	n/a
Equity (Book Value)	1.03B
Book Value Per Share	5.77
Working Capital	530.79M

Cash Flow

In the last 12 months, operating cash flow was 218.71 million and capital expenditures -6.61 million, giving a free cash flow of 212.10 million.

Operating Cash Flow	218.71M
Capital Expenditures	-6.61M
Depreciation & Amortization	147.29M
Net Borrowing	-412.83M
Free Cash Flow	212.10M
FCF Per Share	n/a

Margins

Gross margin is 69.50%, with operating and profit margins of -6.46% and -7.92%.

Gross Margin	69.50%
Operating Margin	-6.46%
Pretax Margin	-9.31%
Profit Margin	-7.92%
EBITDA Margin	1.31%
EBIT Margin	-6.46%
FCF Margin	11.28%

Dividends & Yields

Teladoc Health does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.32%
Shareholder Yield	-3.32%
Earnings Yield	-20.78%
FCF Yield	29.61%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Teladoc Health has an Altman Z-Score of -6.46 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-6.46
Piotroski F-Score	4